Federal funding for biomedical research pays off by enabling basic discoveries that lead to lifesaving treatments, writes Hopkins biologist Jeff Coller
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins
A new platform designed by Hopkins researchers, in partnership with the University of Washington, shows promise in the sped up design of lipid nanoparticles to deliver treatments that prevent viral infections